Accuray to Acquire TomoTherapy for Approximately $277 Million

Accuray ARAY and TomoTherapy Incorporated TOMO, creator of advanced radiation therapy solutions for cancer care, today announced that they have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&AHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!